In addition to changes in UGT1A1, polymorphisms in the transporter proteins SLCO1B1 and ABCB1 have been reported to influence the response of osteoarthritis patients to raloxifene treatment [34,35]. Here, SLCO1B1 is linked to osteoarthritis.